NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Notice of meeting of the Board of Directors28-03-2024
28-03-2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201528-03-2024
NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Year Ended March 31, 2024; And Recommend Dividend On Equity Shares Of The Company, If Any, For The Financial Year Ended March 31, 2024
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2024; and recommend dividend on equity shares of the Company, if any, for the financial year ended March 31, 202427-03-2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-03-2024
NOVARTIS INDIA LTD. - 500672 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Declaration of Voting Results and Scrutinizer''s Report22-03-2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517-03-2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201513-03-2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511-03-2024
Ranjit Shahani, pharma veteran and former VC, MD of Novartis India, passes away
Shahani, 74, was Novartis' India chief when the Swiss drugmaker was involved in a brutal 7-year patent battle over its blood cancer drug Glivec.10-03-2024